Congressional trading
Who in Congress traded LLY?
Eli Lilly and Company Common Stock · classified as Health care. 51 disclosed transactions across 14 members.
51
Transactions
14
Members
13 / 38
Buys / sells
9
Filed late
Committee overlap
4 of 14 members who traded LLY sit on a committee with jurisdiction over Health care. This is a disclosed structural overlap, not evidence of wrongdoing. Nothing here asserts that any member acted on non-public information. Jurisdiction is mapped from published House and Senate committee rules — see the methodology.
Members
18 transactions- Partial sell2025-05-13$1,001 - $15,000(Joint)disclosed after 22dfiling
- Buy2025-05-01$1,001 - $15,000(Joint)disclosed after 34dfiling
- Partial sell2025-04-09$1,001 - $15,000(Joint)disclosed after 34dfiling
- Partial sell2025-03-10$1,001 - $15,000(Joint)disclosed after 25dfiling
- Partial sell2025-02-19$1,001 - $15,000(Joint)disclosed after 14dfiling
- Partial sell2025-01-08$1,001 - $15,000(Joint)disclosed after 29dfiling
4 transactions
4 transactionsCommittee overlap
4 transactions2 filed past the 45-day deadline
4 transactions2 filed past the 45-day deadline
3 transactions
3 transactions2 filed past the 45-day deadline
2 transactionsCommittee overlap
2 transactionsCommittee overlap1 filed past the 45-day deadline
2 transactions1 filed past the 45-day deadline
1 transaction- Buy2026-04-02$1,001 - $15,000(Spouse)disclosed after 29dfiling
1 transactionCommittee overlap1 filed past the 45-day deadline- Sell2026-03-27$1,001 - $15,000disclosed after 116dfiling
1 transaction- Buy2025-10-24$1,001 - $15,000(Spouse)disclosed after 11dfiling
Where this comes from
41 transactions from House Clerk Periodic Transaction Reports and 10 from Senate eFD filings. Amounts are the statutory brackets filers report — Congress does not disclose exact values. Senate filings carry one filing date per report rather than per transaction, so “disclosed after” for a Senate row is measured to the date the whole report was filed. This page is a conflict-of-interest disclosure, not investment advice or a trading signal.